Mugglehead
Advocacy group drafts medical psilocybin framework for regulated access

Advocates have drafted a framework for regulated access to psilocybin for medical and therapeutic uses one year to the day since the first psilocybin exemptions were granted in Canada.

On Tuesday, Victoria-based non-profit TheraPsil released the legalization framework, Access to Psilocybin for Medical Purposes Regulations (APMPR), after consulting with patients, lawyers and regulatory experts.

Learn More

Share this post